Chie Fujisawa Selected Research

SRP 299

1/2005

Mycobacterium vaccae reduces scratching behavior but not the rash in NC mice with eczema: a randomized, blinded, placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chie Fujisawa Research Topics

Disease

6	Menkes Kinky Hair Syndrome (Menkes Disease) 04/2019 - 03/2011
2	Wounds and Injuries (Trauma) 01/2022 - 12/2016
2	Hepatolenticular Degeneration (Wilson's Disease) 03/2012 - 03/2011
2	Occipital horn syndrome 03/2012 - 03/2011
2	Inborn Genetic Diseases (Disease, Hereditary) 03/2012 - 03/2011
1	Fibrosis (Cirrhosis) 01/2022
1	Body Weight (Weight, Body) 06/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2012
1	Acute Liver Failure (Fulminant Hepatic Failure) 03/2012
1	Hypothyroidism 08/2011
1	Neurologic Manifestations (Neurological Manifestations) 03/2011
1	Exanthema (Rash) 01/2005
1	Atopic Dermatitis (Atopic Eczema) 01/2005
1	Pruritus (Itching) 01/2005
1	Eczema 01/2005

Drug/Important Bio-Agent (IBA)

6	CopperIBA 04/2019 - 03/2011
2	Collagen Type I (Type I Collagen)IBA 01/2022 - 12/2016
2	Disulfiram (Antabuse)FDA Link 05/2014 - 06/2012
2	ZincIBA 03/2012 - 03/2011
2	Chelating AgentsIBA 03/2012 - 03/2011
1	CollagenIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	P-type ATPasesIBA 04/2019
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 12/2016
1	Phosphotransferases (Kinase)IBA 12/2016
1	ProcollagenIBA 12/2016
1	Messenger RNA (mRNA)IBA 12/2016
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2016
1	Small Interfering RNA (siRNA)IBA 12/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016
1	Pyruvaldehyde (Methylglyoxal)IBA 09/2012
1	EnzymesIBA 03/2012
1	IodineIBA 08/2011
1	SuspensionsIBA 01/2005
1	SRP 299IBA 01/2005

Therapy/Procedure

1	Oral Administration 06/2012
1	Subcutaneous Injections 06/2012
1	Therapeutics 06/2012
1	Aftercare (After-Treatment) 03/2011
1	Cutaneous Administration 01/2005